日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/01 | 7,420 | 7,510 | 7,310 | 7,340 | -110 | -1.5% | 166,400 |
| 2022/02/28 | 7,320 | 7,470 | 7,300 | 7,450 | +90 | +1.2% | 160,600 |
| 2022/02/25 | 7,400 | 7,430 | 7,250 | 7,360 | ±0 | ±0% | 192,400 |
| 2022/02/24 | 7,380 | 7,430 | 7,280 | 7,360 | -100 | -1.3% | 152,300 |
| 2022/02/22 | 7,510 | 7,510 | 7,360 | 7,460 | -110 | -1.5% | 137,000 |
| 2022/02/21 | 7,560 | 7,630 | 7,510 | 7,570 | -140 | -1.8% | 107,500 |
| 2022/02/18 | 7,550 | 7,740 | 7,550 | 7,710 | +40 | +0.5% | 141,300 |
| 2022/02/17 | 7,770 | 7,790 | 7,630 | 7,670 | -150 | -1.9% | 162,400 |
| 2022/02/16 | 7,800 | 7,860 | 7,700 | 7,820 | +50 | +0.6% | 186,600 |
| 2022/02/15 | 7,740 | 7,820 | 7,680 | 7,770 | +20 | +0.3% | 201,100 |
| 2022/02/14 | 7,540 | 7,780 | 7,500 | 7,750 | -20 | -0.3% | 198,000 |
| 2022/02/10 | 7,710 | 7,840 | 7,680 | 7,770 | +70 | +0.9% | 200,500 |
| 2022/02/09 | 7,680 | 7,760 | 7,630 | 7,700 | +40 | +0.5% | 152,900 |
| 2022/02/08 | 7,630 | 7,700 | 7,560 | 7,660 | +20 | +0.3% | 154,700 |
| 2022/02/07 | 7,650 | 7,690 | 7,610 | 7,640 | -10 | -0.1% | 130,500 |
| 2022/02/04 | 7,520 | 7,680 | 7,520 | 7,650 | +70 | +0.9% | 123,700 |
| 2022/02/03 | 7,530 | 7,610 | 7,490 | 7,580 | -30 | -0.4% | 111,200 |
| 2022/02/02 | 7,470 | 7,640 | 7,470 | 7,610 | +120 | +1.6% | 118,600 |
| 2022/02/01 | 7,550 | 7,660 | 7,470 | 7,490 | +20 | +0.3% | 106,500 |
| 2022/01/31 | 7,470 | 7,520 | 7,390 | 7,470 | ±0 | ±0% | 189,000 |
| 2022/01/28 | 7,510 | 7,640 | 7,400 | 7,470 | -70 | -0.9% | 189,800 |
| 2022/01/27 | 7,600 | 7,610 | 7,500 | 7,540 | -130 | -1.7% | 181,900 |
| 2022/01/26 | 7,630 | 7,750 | 7,610 | 7,670 | +70 | +0.9% | 242,300 |
| 2022/01/25 | 7,400 | 7,630 | 7,340 | 7,600 | +150 | +2% | 218,000 |
| 2022/01/24 | 7,260 | 7,490 | 7,250 | 7,450 | +100 | +1.4% | 135,200 |
| 2022/01/21 | 7,420 | 7,440 | 7,320 | 7,350 | -70 | -0.9% | 175,000 |
| 2022/01/20 | 7,260 | 7,490 | 7,260 | 7,420 | +160 | +2.2% | 173,200 |
| 2022/01/19 | 7,470 | 7,500 | 7,260 | 7,260 | -320 | -4.2% | 181,300 |
| 2022/01/18 | 7,730 | 7,740 | 7,570 | 7,580 | -70 | -0.9% | 92,200 |
| 2022/01/17 | 7,670 | 7,780 | 7,630 | 7,650 | +10 | +0.1% | 82,700 |
| 2022/01/14 | 7,720 | 7,770 | 7,530 | 7,640 | -140 | -1.8% | 179,200 |
| 2022/01/13 | 7,900 | 7,910 | 7,760 | 7,780 | -190 | -2.4% | 127,400 |
| 2022/01/12 | 7,880 | 8,010 | 7,860 | 7,970 | +190 | +2.4% | 141,600 |
| 2022/01/11 | 7,830 | 7,870 | 7,710 | 7,780 | -10 | -0.1% | 171,800 |
| 2022/01/07 | 7,840 | 7,920 | 7,760 | 7,790 | -100 | -1.3% | 157,500 |
| 2022/01/06 | 7,870 | 7,920 | 7,840 | 7,890 | -70 | -0.9% | 168,800 |
| 2022/01/05 | 7,990 | 8,060 | 7,920 | 7,960 | -70 | -0.9% | 198,800 |
| 2022/01/04 | 8,060 | 8,070 | 7,920 | 8,030 | +20 | +0.2% | 133,400 |
| 2021/12/30 | 8,030 | 8,110 | 8,010 | 8,010 | -80 | -1% | 79,400 |
| 2021/12/29 | 8,210 | 8,210 | 7,970 | 8,090 | -120 | -1.5% | 144,000 |
| 2021/12/28 | 8,120 | 8,260 | 8,090 | 8,210 | +90 | +1.1% | 91,100 |
| 2021/12/27 | 8,100 | 8,160 | 8,070 | 8,120 | ±0 | ±0% | 61,500 |
| 2021/12/24 | 8,190 | 8,210 | 8,050 | 8,120 | -60 | -0.7% | 99,500 |
| 2021/12/23 | 8,330 | 8,340 | 8,150 | 8,180 | -40 | -0.5% | 109,900 |
| 2021/12/22 | 8,120 | 8,220 | 8,080 | 8,220 | +100 | +1.2% | 178,500 |
| 2021/12/21 | 8,100 | 8,190 | 8,040 | 8,120 | +160 | +2% | 149,100 |
| 2021/12/20 | 7,790 | 7,960 | 7,780 | 7,960 | +110 | +1.4% | 155,700 |
| 2021/12/17 | 8,080 | 8,120 | 7,800 | 7,850 | -270 | -3.3% | 266,800 |
| 2021/12/16 | 8,120 | 8,170 | 8,080 | 8,120 | +80 | +1% | 128,000 |
| 2021/12/15 | 8,020 | 8,120 | 8,010 | 8,040 | -50 | -0.6% | 134,400 |
801～
850
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
